Exploristics | Transforming Clinical Trial Design
Biotechnology ResearchView the employees at
Exploristics | Transforming Clinical Trial Design-
Shane Donnelly Analyst Graduate
-
Belfast, Northern Ireland, United Kingdom
-
Rising Star
Adrian Szysler Software Engineer at Exploristics-
Belfast Metropolitan Area
-
Rising Star
Frances D. Business Operations Manager at Exploristics Ltd-
Belfast Metropolitan Area
-
Rising Star
Catherine Mc Hugh Senior Statistician at Exploristics-
Strabane, Northern Ireland, United Kingdom
-
Rising Star
Jamie Inshaw Principal Consultant Statistician and Team Lead at Exploristics Ltd-
Rising Star
Overview
Exploristics is a global provider of specialised software products and technology-enabled services to the pharmaceutical, biotechnology, medical diagnostics and devices sector. We offer statistical consultancy, biostatistics and data science services to organisations of all sizes, smoothing their clinical development path. Our experienced statisticians, programmers, data scientists and software engineers develop and apply robust methods and technologies offering data-driven insights that support clinical researchers in the design, analysis and reporting of clinical trials. As a company, we invest substantially in in-house R&D. This has resulted in the development of the innovative cloud-based study simulation platform, KerusCloud. This software provides an invaluable tool for designing smarter clinical studies helping to identify the key drivers of study success and so improve outcomes. With uniquely realistic simulation capabilities, KerusCloud offers a powerful, practical and cost-effective solution to selecting the best design and analysis options for a clinical study. It allows prospective optimisation of multiple study uncertainties in a virtual environment, ensuring that real trials are suitably designed to answer the challenges facing current clinical research. This approach has been shown to substantially de-risk studies, reducing development timelines, costs and patient burden. We seek to transform clinical development approaches with our state-of-the-art technology-enabled consultancy services and so accelerate the delivery of new therapeutics to those with unmet clinical need.
-